Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors
Cells Tissues Organs · 28.08.2024 · 1-11
DOI: 10.1159/000539699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells Tissues Organs, online erschienen am 28.08.2024. Verfasst von Sanjoy Saha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, University of Notre Dame, Notre Dame, Indiana, USA. Hauptthemen laut MEDLINE: Cell Differentiation, Endothelial Cells, Transcription Factors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Introduction
Generating new lymphatic vessels has been postulated as an innovative therapeutic strategy for various disease phenotypes, including neurodegenerative diseases, metabolic syndrome, cardiovascular disease, and lymphedema. Yet, compared to the blood vascular system, protocols to differentiate human induced pluripotent stem cells (hiPSCs) into lymphatic endothelial cells (LECs) are still lacking.
Methods
Transcription factors, ETS2 and ETV2 are key regulators of embryonic vascular development, including lymphatic specification. While ETV2 has been shown to efficiently generate blood endothelial cells, little is known about ETS2 and its role in lymphatic differentiation. Here, we describe a method for rapid and efficient generation of LECs using transcription factors, ETS2 and ETV2.
Results
This approach reproducibly differentiates four diverse hiPSCs into LECs with exceedingly high efficiency. Timely activation of ETS2 was critical, to enable its interaction with Prox1, a master lymphatic regulator. Differentiated LECs express key lymphatic markers, VEGFR3, LYVE-1, and Podoplanin, in comparable levels to mature LECs. The differentiated LECs are able to assemble into stable lymphatic vascular networks in vitro, and secrete key lymphangiocrine, reelin.
Conclusion
Overall, our protocol has broad applications for basic study of lymphatic biology, as well as toward various approaches in lymphatic regeneration and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, University of Notre Dame, Notre Dame, Indiana, USA.
- Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, Indiana, USA.
- Center for Stem Cells and Regenerative Medicine, University of Notre Dame, Notre Dame, Indiana, USA.
- Department of Biological Science, University of Notre Dame, Notre Dame, Indiana, USA.
- Boler-Parseghian Center for Rare Diseases, University of Notre Dame, Notre Dame, Indiana, USA.
Förderung
- NIGMS NIH HHS
Zitieren
APA
Saha, S., Graham, F., Knopp, J., Patzke, C., & Hanjaya-Putra, D. (2024). Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors. Cells Tissues Organs, 1-11. https://doi.org/10.1159/000539699
Vancouver
Saha S, Graham F, Knopp J, Patzke C, Hanjaya-Putra D. Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors. Cells Tissues Organs. 2024:1-11. doi:10.1159/000539699
BibTeX
@article{Saha2024,
author = {Saha, Sanjoy and Graham, Francine and Knopp, James and Patzke, Christopher and Hanjaya-Putra, Donny},
title = {Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors},
journal = {Cells Tissues Organs},
year = {2024},
pages = {1--11},
doi = {10.1159/000539699}
}
EUVIMED